Literature DB >> 18705999

Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal approaches.

.   

Abstract

BACKGROUND: Many acute stroke trials have given neutral results. Sub-optimal statistical analyses may be failing to detect efficacy. Methods which take account of the ordinal nature of functional outcome data are more efficient. We compare sample size calculations for dichotomous and ordinal outcomes for use in stroke trials.
METHODS: Data from stroke trials studying the effects of interventions known to positively or negatively alter functional outcome--Rankin Scale and Barthel Index--were assessed. Sample size was calculated using comparisons of proportions, means, medians (according to Payne), and ordinal data (according to Whitehead). The sample sizes gained from each method were compared using Friedman 2 way ANOVA.
RESULTS: Fifty-five comparisons (54 173 patients) of active vs. control treatment were assessed. Estimated sample sizes differed significantly depending on the method of calculation (P<0.0001). The ordering of the methods showed that the ordinal method of Whitehead and comparison of means produced significantly lower sample sizes than the other methods. The ordinal data method on average reduced sample size by 28% (inter-quartile range 14-53%) compared with the comparison of proportions; however, a 22% increase in sample size was seen with the ordinal method for trials assessing thrombolysis. The comparison of medians method of Payne gave the largest sample sizes.
CONCLUSIONS: Choosing an ordinal rather than binary method of analysis allows most trials to be, on average, smaller by approximately 28% for a given statistical power. Smaller trial sample sizes may help by reducing time to completion, complexity, and financial expense. However, ordinal methods may not be optimal for interventions which both improve functional outcome and cause hazard in a subset of patients, e.g. thrombolysis.

Entities:  

Mesh:

Year:  2008        PMID: 18705999     DOI: 10.1111/j.1747-4949.2008.00184.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  18 in total

1.  Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA).

Authors:  Jeffrey L Saver; Bogdan Filip; Scott Hamilton; Anna Yanes; Sharon Craig; Michelle Cho; Robin Conwit; Sidney Starkman
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

Review 2.  Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

3.  Prehospital randomised assessment of a mechanical compression device in cardiac arrest (PaRAMeDIC) trial protocol.

Authors:  Gavin D Perkins; Malcolm Woollard; Matthew W Cooke; Charles Deakin; Jessica Horton; Ranjit Lall; Sarah E Lamb; Chris McCabe; Tom Quinn; Anne Slowther; Simon Gates
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-11-05       Impact factor: 2.953

4.  Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol.

Authors:  Joanna M Wardlaw; Fergus Doubal; Rosalind Brown; Ellen Backhouse; Lisa Woodhouse; Philip Bath; Terence J Quinn; Thompson Robinson; Hugh S Markus; Richard McManus; John T O'Brien; David J Werring; Nikola Sprigg; Adrian Parry-Jones; Rhian M Touyz; Steven Williams; Yee-Haur Mah; Hedley Emsley
Journal:  Eur Stroke J       Date:  2020-10-11

5.  Immediate effects of acupuncture on biceps brachii muscle function in healthy and post-stroke subjects.

Authors:  Ana Paula S Fragoso; Arthur S Ferreira
Journal:  Chin Med       Date:  2012-03-14       Impact factor: 5.455

6.  Comparisons of Analysis Methods for Proof-of-Concept Trials.

Authors:  K E Karlsson; C Vong; M Bergstrand; E N Jonsson; M O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-01-16

7.  Head Position in Stroke Trial (HeadPoST)--sitting-up vs lying-flat positioning of patients with acute stroke: study protocol for a cluster randomised controlled trial.

Authors:  Paula Muñoz-Venturelli; Hisatomi Arima; Pablo Lavados; Alejandro Brunser; Bin Peng; Liying Cui; Lily Song; Laurent Billot; Elizabeth Boaden; Maree L Hackett; Stephane Heritier; Stephen Jan; Sandy Middleton; Verónica V Olavarría; Joyce Y Lim; Richard I Lindley; Emma Heeley; Thompson Robinson; Octavio Pontes-Neto; Lkhamtsoo Natsagdorj; Ruey-Tay Lin; Caroline Watkins; Craig S Anderson
Journal:  Trials       Date:  2015-06-05       Impact factor: 2.279

8.  Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.

Authors:  Philip M W Bath; Katie Robson; Lisa J Woodhouse; Nikola Sprigg; Robert Dineen; Stuart Pocock
Journal:  Int J Stroke       Date:  2014-12-30       Impact factor: 5.266

9.  A novel Longshi Scale measured activity of daily living disability in elderly patients affected by neurological diseases: a multi-center cross-sectional study in China.

Authors:  Jingpu Zhao; Xiangxiang Liu; Li Wan; Yan Gao; Meiling Huang; Fubing Zha; Jianjun Long; Dongxia Li; Guohui Nie; Yulong Wang
Journal:  BMC Geriatr       Date:  2021-06-05       Impact factor: 3.921

10.  Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids.

Authors:  Daniel J Blackburn; Kailash Krishnan; Lydia Fox; Clive Ballard; Alistair Burns; Gary A Ford; Jonathan Mant; Peter Passmore; Stuart Pocock; John Reckless; Nikola Sprigg; Rob Stewart; Joanna Wardlaw; Philip M W Bath
Journal:  Trials       Date:  2013-11-22       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.